P. Dombernowsky

发表

Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.

I. Strøyer, H. Hansen, N. Nissen, 1975, Cancer chemotherapy reports.

Histology and cell proliferation in human bladder tumors. An autoradiographic study

P. Dombernowsky, B. Hainau, Department, 1974, Cancer.

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

F. Hirsch, H. Hansen, P. Dombernowsky, 1999, British Journal of Cancer.

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

P. Dombernowsky, J. Hansen, B. Jensen, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

P. Andersen, P. Dombernowsky, T. Skovsgaard, 2005, Breast Cancer Research and Treatment.

Assessment of CA 15.3, CEA and TPA Concentrations during Monitoring of Breast Cancer

P. H. Petersen, P. Dombernowsky, G. Sölétormos, 2000, Clinical Chemistry and Laboratory Medicine.

Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation.

P. Dombernowsky, G. Sölétormos, D. Nielsen, 1993, Clinical chemistry.

A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA.

H. Mouridsen, P. Dombernowsky, G. Sölétormos, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

H. Hansen, M. Hansen, P. Dombernowsky, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.

H. Hansen, M. Hansen, P. Dombernowsky, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.

P. Dombernowsky, N. Thatcher, H. Anderson, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma

J. Bennedsen, S. Larsen, P. Dombernowsky, 2004, Cancer Immunology, Immunotherapy.

Bone‐marrow examination in the staging of small‐cell anaplastic carcinoma of the lung with special reference to subtyping: An evaluation of 203 consecutive patients

F. Hirsch, H. Hansen, P. Dombernowsky, 1977, Cancer.

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

I. Christensen, L. Bastholt, H. Mouridsen, 2000, Breast Cancer Research and Treatment.

Adjuvant radiotherapy and risk of contralateral breast cancer.

A. Jacobsen, M. Blettner, M. Stovall, 1992, Journal of the National Cancer Institute.

Treatment of advanced breast cancer with tamoxifen: Evaluation of the dose-response relationship at two dose levels

H. Mouridsen, P. Dombernowsky, C. Rose, 1982, Breast Cancer Research and Treatment.

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

P. Dombernowsky, J. Herrstedt, J. Handberg, 2007, Supportive Care in Cancer.

Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.

P. Andersen, H. Hansen, P. Dombernowsky, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

H. Hansen, P. Dombernowsky, B. Bergman, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients.

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1985, Thorax.

Induction therapy for NSCLC: a consensus report

R. Mirimanoff, R. Ginsberg, A. Gregor, 1991 .

Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy

F. Hirsch, H. Hansen, P. Dombernowsky, 1980, Cancer.

Phase-I study of α-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934)

H. Hansen, P. Dombernowsky, B. Lund, 2004, Cancer Chemotherapy and Pharmacology.

Phase II study of teniposide in adenocarcinoma of the lung

H. Hansen, P. Dombernowsky, J. Sørensen, 2004, Cancer Chemotherapy and Pharmacology.

Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA.

P. Dombernowsky, G. Sölétormos, D. Nielsen, 2004, European journal of cancer.

Phase II study of teniposide in advanced breast cancer

P. Dombernowsky, S. Engelholm, O. P. Hansen, 2004, Cancer Chemotherapy and Pharmacology.

Ondansetron P lus M etopimazine C ompared W ith Ondansetron P lus M etopimazine P lus P rednisolone a s Antiemetic P rophylaxis i n P atients R eceiving M ultiple Cycles o f M oderately E metogenic C hemotherapy

P. Dombernowsky, J. Herrstedt, J. Handberg, 2001 .

Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

P. Dombernowsky, J. Herrstedt, H. Lund, 1999, British Journal of Cancer.

Evaluation of the optimal duration of chemotherapy in phase II trials for inoperable non-small-cell lung cancer (NSCLC).

H. Hansen, P. Dombernowsky, J. Sørensen, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of serum tetranectin in patients with metastatic breast cancer.

B. No̸rgaard-Pedersen, P. Dombernowsky, I. Clemmensen, 1993, Acta oncologica.

Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.

H. Hansen, P. Dombernowsky, P. Oturai, 1993, European journal of cancer.

Carbohydrate antigen 549 in metastatic breast cancer during cytostatic treatment and follow-up.

P. Dombernowsky, G. Sölétormos, D. Nielsen, 1992, European journal of cancer.

Effects of intensive chemotherapy on respiratory function in patients with small cell carcinoma of the lung.

P. Dombernowsky, S. Groth, K. Osterlind, 1983, European journal of cancer & clinical oncology.

Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer.

A. Pedersen, P. Dombernowsky, F. Bach, 1989, European journal of cancer & clinical oncology.

A phase II trial of peplomycin in squamous cell carcinoma of the lung.

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1983, European journal of cancer & clinical oncology.

Metastatic spinal cord compression secondary to lung cancer.

P. Sørensen, H. Hansen, P. Dombernowsky, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peritoneoscopy in the staging of 190 patients with small‐cell anaplastic carcinoma of the lung with special reference to subtyping

F. Hirsch, H. Hansen, P. Dombernowsky, 1978, Cancer.

Carcino-embryonic antigen in monitoring the growth of human colon adenocarcinoma tumour cells SK-CO-1 and HT-29 in vitro and in nude mice.

P. Dombernowsky, M. Spang‐Thomsen, G. Sölétormos, 1997, European journal of cancer.

Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.

J. Verweij, H. Mouridsen, A. V. van Oosterom, 1992, Seminars in oncology.

Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

M. Highley, F. Hirsch, J. Carmichael, 2001, Anti-cancer drugs.

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.

P. Dombernowsky, O. Munck, H. Havsteen, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic pattern in non-resectable non-small cell lung cancer.

P. Dombernowsky, J. Sørensen, L. Stenbygaard, 1999, Acta oncologica.

Role of radiation therapy in small cell anaplastic carcinoma of the lung.

R. Wittes, P. Bunn, N. Bleehen, 1983, Cancer treatment reports.

Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.

H. Hansen, P. Dombernowsky, K. Osterlind, 1981, Cancer treatment reports.

Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination.

F. Hirsch, H. Hansen, P. Dombernowsky, 1978, Annals of internal medicine.

The limited value of routine chest X-ray in the follow-up of stage II breast cancer.

K. Zedeler, P. Dombernowsky, H. Thomsen, 1990, European journal of cancer.

The value of yearly chest X-ray in patients with stage I breast cancer.

K. Zedeler, P. Dombernowsky, H. Thomsen, 1989, European journal of cancer & clinical oncology.

Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer.

P. H. Petersen, P. Dombernowsky, G. Sölétormos, 1999, Gynecologic oncology.

Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up.

P. Dombernowsky, G. Sölétormos, D. Nielsen, 1996, Clinical chemistry.

Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.

P. Dombernowsky, J. Herrstedt, M. Hansen, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complications of Chemotherapy

P. Dombernowsky, K. Peschardt, J. Herrstedt, 2009 .

Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil

P. Dombernowsky, O. Munck, J. Godtfredsen, 2004, Cancer Chemotherapy and Pharmacology.

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy.

P. Dombernowsky, T. Skovsgaard, K. Osterlind, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas.

R. Sylvester, A. Santoro, H. Mouridsen, 1987, European journal of cancer & clinical oncology.

Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.

J. Gehl, P. Dombernowsky, B. Jensen, 1996, Seminars in oncology.

Doxorubicin plus paclitaxel in advanced breast cancer.

P. Dombernowsky, B. Jensen, M. Boesgaard, 1997, Seminars in oncology.

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study

P. Dombernowsky, T. Skovsgaard, D. Nielsen, 2000, Cancer Chemotherapy and Pharmacology.

Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.

L. Bastholt, H. Mouridsen, P. Dombernowsky, 1986, Breast cancer research and treatment.

Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.

F. Hirsch, H. Hansen, P. Kristjansen, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study.

P. Dombernowsky, S. Engelholm, T. Skovsgaard, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?

F. Hirsch, P. Dombernowsky, B. Bergman, 1997, Lung cancer.

Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer.

H. Hansen, P. Dombernowsky, J. Sørensen, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer

H. Hansen, P. Dombernowsky, J. Sørensen, 1999 .

Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer

H. Hansen, P. Dombernowsky, B. Bergman, 1999, British Journal of Cancer.

Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials.

H. Mouridsen, P. Dombernowsky, C. Rose, 1986, NCI monographs : a publication of the National Cancer Institute.

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma.

J. Verweij, A. Santoro, H. Mouridsen, 1993, Cancer chemotherapy and pharmacology.

Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinoma.

F. Hirsch, H. Hansen, P. Dombernowsky, 1978, Seminars in oncology.

Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49A.

P. Dombernowsky, N. Brünner, J. Herrstedt, 1994, European journal of cancer.

5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1981, Cancer treatment reports.

Phase II trial of prednimustine, L‐1031, (NSC‐134087) in advanced breast cancer

H. Mouridsen, P. Dombernowsky, H. Mouridsen, 1980, Cancer.

Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.

P. Dombernowsky, J. Herrstedt, M. Boesgaard, 1993, The New England journal of medicine.

Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.

P. Dombernowsky, S. Engelholm, D. Nielsen, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of teniposide in small cell carcinoma of the lung.

H. Hansen, P. Dombernowsky, K. Osterlind, 1984, Cancer treatment reports.

[Normalization of obstructive lung insufficiency in patients under cytostatic treatment for small cell anaplastic lung carcinoma].

M. Schroll, P. Dombernowsky, K. Osterlind, 1980, Ugeskrift for laeger.

Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic.

J. Gehl, P. Dombernowsky, B. Jensen, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Cell proliferation and histologic classification of bronchogenic carcinoma.

H. Hansen, P. Dombernowsky, B. Hainau, 1977, Journal of the National Cancer Institute.

Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer.

D. Amadori, G. Sledge, S. Arbuck, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy in the management of superior vena caval obstruction in small-cell anaplastic carcinoma of the lung.

H. Hansen, P. Dombernowsky, 2009, Acta medica Scandinavica.

Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF Combination with epirubicin

J. Bergh, H. Mouridsen, M. Andersson, 1999 .

Treatment of metastatic breast cancer with paclitaxel and doxorubicin.

J. Gehl, P. Dombernowsky, B. Ejlertsen, 1995, Seminars in oncology.

Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy

P. Dombernowsky, J. Herrstedt, T. Sigsgaard, 2000, Supportive Care in Cancer.

Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7 LCC1 and MCF-7 LCC2

N. Brünner, R. Clarke, P. Dombernowsky, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.

H. Hansen, P. Dombernowsky, J. Aisner, 1979, Cancer treatment reports.

Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP‐16‐213 (NSC 141540, 4′‐demethylepipodophyllotoxin 9‐(4,6‐0‐ethylidene‐β‐D‐glucopyranoside)

F. Hirsch, H. Hansen, P. Dombernowsky, 1977, Cancer.

Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.

P. Dombernowsky, S. Monfardini, H. Pinedo, 1988, European Journal of Cancer and Clinical Oncology.

Small Cell Anaplastic Carcinoma of the Lung: Staging

H. Hansen, P. Dombernowsky, 1981 .

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P. Dombernowsky, J. Bellmunt, T. Hatschek, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung

J. Bennedsen, P. Dombernowsky, H. Nielsen, 2004, Cancer Immunology, Immunotherapy.

Anti-emetic therapy in cancer chemotherapy: current status.

P. Dombernowsky, J. Herrstedt, 2007, Basic & clinical pharmacology & toxicology.

Population Pharmacokinetic and Dynamic Analysis of the Topoisomerase I Inhibitor Lurtotecan in Phase II Studies

M. Gore, R. Paridaens, J. Wanders, 2002, Investigational New Drugs.

Hypouricaemia and inappropriate secretion of antidiuretic hormone in small cell bronchogenic carcinoma.

P. Dombernowsky, K. Osterlind, M. Hansen, 2009, Acta medica Scandinavica.

Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy.

P. Dombernowsky, J. Herrstedt, M. Kjaer, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.

J. Gehl, P. Dombernowsky, B. Jensen, 1996, Seminars in oncology.

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer

M. Ro̸rth, H. Mouridsen, P. Dombernowsky, 1983, Cancer.

Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial.

P. Dombernowsky, A. Jakobsen, H. Brincker, 1986, European journal of cancer & clinical oncology.

Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy.

P. Dombernowsky, H. Thomsen, K. Andersen, 1987, European journal of cancer & clinical oncology.

Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.

J. Verweij, R. Sylvester, A. Santoro, 1993, Cancer chemotherapy and pharmacology.

CYTOKINETIC STUDIES OF THE REGENERATIVE PHASE IN THE JB‐1 ASCITES TUMOUR

P. Dombernowsky, P. Bichel, N. R. Hartmann, 1974, Cell and tissue kinetics.

RECYCLING OF RESTING CELLS IN THE JB‐1 ASCITES TUMOUR AFTER TREATMENT WITH 1‐β‐D‐ARABINOFURANOSYLCYTOSINE (Ara‐C)

P. Dombernowsky, P. BlCHEL, 1976, Cell and tissue kinetics.

Cytokinetic variations during ageing and regenerative growth in the jb-1 ascites tumour studied by impulse cytophotometry.

P. Dombernowsky, P. Bichel, 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

Resting stages of the JB-1 ascites tumour in the irradiated mouse.

P. Dombernowsky, P. Bichel, 1975, European journal of cancer.

Autoradiographic and cytophotometric analyses of the resting stages of the L1210 ascites tumor.

P. Dombernowsky, N. R. Hartmann, 1974, Cancer research.

CYTOKINETIC ANALYSIS OF THE JB‐1 ASCITES TUMOUR AT DIFFERENT STAGES OF GROWTH

P. Dombernowsky, P. Bichel, N. R. Hartmann, 1973, Cell and tissue kinetics.

ON THE RESTING STAGES OF THE JB‐1 ASCITES TUMOUR

P. Dombernowsky, P. Bichel, 1973, Cell and tissue kinetics.

The proliferation kinetics of L 1210 ascites tumour.

P. Dombernowsky, 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

Analysis of variations in the cell population kinetics with tumor age in the L1210 ascites tumor.

P. Dombernowsky, N. R. Hartmann, 1972, Cancer research.

Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.

N. Nissen, P. Dombernowsky, 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

Tumor markers in the management of patients with ovarian cancer.

P. Dombernowsky, G. Sölétormos, M. Tuxen, 1995, Cancer treatment reviews.

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.

H. Hansen, P. Dombernowsky, J. Sørensen, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.

O. S. Nielsen, M. van Glabbeke, J. Verweij, 2002, European journal of cancer.

Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up

P. Dombernowsky, G. Sölétormos, M. Tuxen, 2002, Scandinavian journal of clinical and laboratory investigation.

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

P. Dombernowsky, G. Sölétormos, M K Tuxen, 2001, British Journal of Cancer.

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

M. Ro̸rth, S. Larsen, H. Mouridsen, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TREATMENT OF SMALL-CELL CARCINOMA OF BRONCHUS

H. Hansen, P. Dombernowsky, F. Muggia, 1975, The Lancet.

Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.

F. Hirsch, H. Hansen, M. Ro̸rth, 1983, Cancer research.

Long-term survival in small cell carcinoma of the lung.

H. Hansen, P. Dombernowsky, M. Hansen, 1980, JAMA.

Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs.

H. Hansen, P. Dombernowsky, J. Sørensen, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.

F. Hirsch, H. Hansen, P. Dombernowsky, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.

P. Dombernowsky, K. Danø, J. Grøndahl‐Hansen, 1988, The Journal of laboratory and clinical medicine.

Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.

H. Hansen, P. Dombernowsky, K. Osterlind, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of surgical resection prior to chemotherapy on the long-term results in small cell lung cancer. A study of 150 operable patients.

H. Hansen, P. Dombernowsky, K. Osterlind, 1986, European journal of cancer & clinical oncology.

Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer.

P. Andersen, H. Hansen, P. Dombernowsky, 1987, Cancer research.

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients.

F. Hirsch, H. Hansen, P. Dombernowsky, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SMALL-CELL CARCINOMA OF THE BRONCHUS

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1980, The Lancet.

Vincristine (NSC-67574) in the treatment of small-cell anaplastic carcinoma of the lung.

H. Hansen, P. Dombernowsky, B. Hainau, 1976, Cancer treatment reports.

Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial

P. Dombernowsky, J. Herrstedt, J. F. Thomsen, 2004, Breast Cancer Research and Treatment.

Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer

P. Dombernowsky, G. Rustin, G. Sölétormos, 2000, Scandinavian journal of clinical and laboratory investigation.

Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.

B. Rasmussen, H. Mouridsen, P. Dombernowsky, 1988, Acta oncologica.

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group

O. S. Nielsen, M. van Glabbeke, J. Verweij, 2000, Sarcoma.

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.

O. S. Nielsen, M. van Glabbeke, D. Crowther, 1998, British Journal of Cancer.

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1986, British Journal of Cancer.

Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.

H. Mouridsen, M. Andersson, P. Dombernowsky, 1999, European journal of cancer.

VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.

A. Santoro, H. Mouridsen, V. Bramwell, 1987, European journal of cancer & clinical oncology.

Phase II study of 4′-iodo-4′-deoxydoxorubicin in non-resectable non-small-cell lung cancer

H. Hansen, P. Dombernowsky, J. Sørensen, 2004, Cancer Chemotherapy and Pharmacology.

16 Randomized trial in small cell lung cancer comparing the combination of cisplatin and carboplatin with carboplatin alone in combination chemotherapy

F. Hirsch, H. Hansen, P. Dombernowsky, 1997 .

Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.

N. Nissen, P. Dombernowsky, 1976, European journal of cancer.

The epipodophyllotoxin derivatives VM26 and VP16: Experimental and clinical aspects

H. Hansen, P. Dombernowsky, 1989, European journal of haematology. Supplementum.

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG

H. Mouridsen, M. Andersson, P. Dombernowsky, 1999, European journal of cancer.

Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B.

H. Mouridsen, P. Dombernowsky, C. Rose, 1988, Acta oncologica.

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.

H. Mouridsen, P. Dombernowsky, C. Rose, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results.

G. Knudsen, H. Mouridsen, P. Dombernowsky, 1988, Acta oncologica.

The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancer.

P. Dombernowsky, G. Sölétormos, C. Kamby, 1993, Scandinavian journal of clinical and laboratory investigation.

Letter: Treatment of small-cell carcinoma of bronchus.

H. Hansen, P. Dombernowsky, F. Muggia, 1975, Lancet.

Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.

H. Hansen, M. Ro̸rth, P. Dombernowsky, 1982, Cancer treatment reports.

Comparison of the effect of cortisol on aromatase activity and androgen metabolism in two human fibroblast cell lines derived from the same individual.

P. Dombernowsky, M. Spang‐Thomsen, N. Brünner, 1990, Journal of steroid biochemistry.

84 Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)

P. Postmus, H. Hansen, J. Wanders, 1995 .

Brain CT-scanning and neurological examination in small cell bronchogenic carcinoma

G. Boysen, A. Pedersen, P. Dombernowsky, 2004, Journal of Neuro-Oncology.

Original article: Combination chemotheraphy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens

F. Hirsch, H. Hansen, P. Dombernowsky, 1991 .

The role of thoracic radiation therapy in small cell carcinoma of the lung: a concensus report

G. Giaccone, R. Arriagada, P. Dombernowsky, 1989 .

Ifosfamide plus Adriamycin in Advanced Soft Tissue Sarcomas

R. Sylvester, A. Santoro, H. Mouridsen, 1987 .

Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low‐risk carcinomas from a multicenter trial

B. V. Pedersen, N. Keiding, P. Dombernowsky, 1987, Cancer.

Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.

M. Ro̸rth, H. Mouridsen, P. Dombernowsky, 1980, European journal of cancer.

Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung

H. Hansen, P. Dombernowsky, H. Jensen, 2004, Cancer Chemotherapy and Pharmacology.

Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.

P. Dombernowsky, F. Bach, G. Soletormos, 1991, Journal of the National Cancer Institute.

Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.

H. Hansen, P. Dombernowsky, R. Somers, 1982, European journal of cancer & clinical oncology.

Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG).

J. Wanders, C. Sessa, P. Dombernowsky, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Bioavailability of the antiemetic metopimazine given as a microenema.

P. Dombernowsky, J. Herrstedt, H. Angelo, 2003, British journal of clinical pharmacology.

Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.

N. Nissen, P. Dombernowsky, V. Larsen, 1972, Cancer chemotherapy reports.

The Radner needle a bone-marrow biopsy device.

H. Hansen, N. Nissen, P. Dombernowsky, 2009, Scandinavian journal of haematology.

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group.

J. Verweij, A. Santoro, H. Mouridsen, 1990, European journal of cancer.

[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial].

H. Mouridsen, P. Dombernowsky, C. Rose, 1991, Ugeskrift for læger.

Phase II study of procarbazine in small cell carcinoma of the lung.

H. Hansen, P. Dombernowsky, K. Aabo, 1982, Cancer treatment reports.

[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study].

B. Rasmussen, H. Mouridsen, P. Dombernowsky, 1991, Ugeskrift for laeger.

Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.

P. Dombernowsky, J. Sørensen, K. Wedervang, 1997, Seminars in oncology.

Gemcitabine and paclitaxel combinations in non-small cell lung cancer.

G. Giaccone, P. Dombernowsky, A. Sandler, 1998, Seminars in oncology.

Classical prognostic factors in node-negative breast cancer: the DBCG experience.

B. Rasmussen, H. Mouridsen, P. Dombernowsky, 1992, Journal of the National Cancer Institute. Monographs.

The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.

H. Hansen, N. Nissen, P. Dombernowsky, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

88 Oral etoposide (VP-16) every 3 wks. or continuously to elderly patients with small cell lung cancer (SCLC): Preliminary results of a randomized study

F. Hirsch, P. Dombernowsky, B. Bergman, 1997 .

CAF vs CMF both with tamoxlfen in postmenopausal patients with advanced breast cancer — A randomized study with more than 10 years follow-up from the Danish breast cancer cooperative group

M. Andersson, P. Dombernowsky, M. Overgaard, 1997 .

A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma.

N. Nielsen, H. Hansen, P. Dombernowsky, 1985, European Journal of Cancer and Clinical Oncology.

Iron status markers in patients with small cell carcinoma of the lung. Relation to survival.

N. Milman, H. Sengeløv, P. Dombernowsky, 1991, British Journal of Cancer.

Interpretation of Sequential Measurements of Cancer Antigen 125 (CA 125), Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA) Based on Analytical Imprecision and Biological Variation in the Monitoring of Ovarian Cancer

P. Dombernowsky, G. Sölétormos, M. Tuxen, 2001, Clinical chemistry and laboratory medicine.

High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.

P. Dombernowsky, K. Aabo, A. Pedersen, 1982, Cancer treatment reports.

Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801).

P. Dombernowsky, J. Herrstedt, B. Jeppesen, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Prophylactic lrradia tion in Bronc hogenic Small Cell Anaplastic Carcinoma

F. Hirsch, H. Hansen, P. Dombernowsky, 2006 .

NEUROLOGICAL EXAMINATION AND CT‐SCAN AS SCREENING METHODS FOR CNS METASTASIS IN SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNG.

G. Boysen, P. Dombernowsky, A. Karle, 1982 .

TCNU in adenocarcinoma of the lung: a phase II study with divided doses.

H. Hansen, P. Dombernowsky, J. Sørensen, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.

H. Hansen, P. Dombernowsky, J. Sørensen, 1990, European Journal of Cancer.

TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.

F. Cavalli, P. Dombernowsky, S. Gundersen, 1989, European Journal of Cancer and Clinical Oncology.

Phase II study of TCNU in advanced breast cancer.

A. Howell, P. Dombernowsky, J. Smyth, 1988, European Journal of Cancer and Clinical Oncology.

PHASE I clinical trial of an oral solution of VP-16-213.

H. Hansen, N. Nissen, P. Dombernowsky, 1976, Cancer treatment reports.

Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.

F. Hirsch, H. Hansen, P. Dombernowsky, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[Combination chemotherapy of the superior vena cava syndrome in small cell anaplastic lung carcinoma].

H. Hansen, P. Dombernowsky, 1980, Ugeskrift for læger.

A Phase I study of men-10755 in patients with a solid tumor as a shorti.v. infusion given once every 3 weeks

S. Aamdal, S. Peters, J. Wanders, 1999 .